MEDICUD

MEDICUD is a medical device startup based in Rome, founded in June 2020 by Antonio d'Angelo and Andrea Cazzulani. The company is dedicated to advancing wound healing through sustainable and user-centered medical technologies. MEDICUD aims to lead in sustainable medical solutions, focusing on efficient and environmentally friendly options for wound care. The company's flagship product, DRYUM, is an ultraportable, single-use incisional negative pressure wound therapy (i-NPWT) device. It promotes healing and minimizes surgical complications without the need for embedded electronics, making it cost-effective and easy to use. DRYUM is designed for surgical incisions, with initial clinical trials targeting orthopedic surgeries like Total Hip Arthroplasty and Total Knee Arthroplasty. MEDICUD has raised over €2.5 million in funding to support clinical trials and regulatory processes, with plans for commercialization in the EU and US markets by the first half of 2026. The company is committed to Environmental, Social, and Governance (ESG) principles and aims to reduce the ecological footprint of medical treatments while maximizing value for stakeholders.

• Employees10
• Founded2020